TrademarkDir
FORTESTA (TESTOSTERONE) GEL CIII
DEAD

Serial Number

85432595

Owner

ENDO PHARMACEUTICALS INC.

Attorney

Camille M. Miller

First Use Date

Feb 28, 2011

Filing Date

Sep 27, 2011

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FORTESTA (TESTOSTERONE) GEL CIII Trademark

Serial Number: 85432595 • Registration: 4153422

FORTESTA (TESTOSTERONE) GEL CIII is a trademark filed by ENDO PHARMACEUTICALS INC. on September 27, 2011. The trademark is classified under Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

ENDO PHARMACEUTICALS INC. (200 trademarks)

100 PAINTERS DRIVE (ROUTES 1 AND 202)
CHADDS FORD, PA 19317

Entity Type: 03

Trademark Details

Filing Date

September 27, 2011

Registration Date

June 5, 2012

First Use Anywhere

February 28, 2011

First Use in Commerce

February 28, 2011

Published for Opposition

March 20, 2012

Cancellation Date

January 11, 2019

Goods & Services

Printed educational materials on the subject of testosterone deficiency

Providing online information on the subject of testosterone deficiency

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 28, 2024 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 22, 2021 ASCK
CANCELLED SEC. 8 (6-YR)
Jan 11, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 5, 2017 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2015 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 26, 2014 ASCK
REGISTERED-PRINCIPAL REGISTER
Jun 5, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2012 NPUB
PUBLISHED FOR OPPOSITION
Mar 20, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 29, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 13, 2012 PREV
ASSIGNED TO LIE
Feb 13, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 18, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jan 18, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jan 18, 2012 CNRT
ASSIGNED TO EXAMINER
Jan 17, 2012 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Oct 1, 2011 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2011 NWOS
NEW APPLICATION ENTERED
Sep 30, 2011 NWAP

Related Trademarks

More from this Owner

ENDO GENERICS PAR PHARMACEUTICAL logo

ENDO GENERICS PAR PHARMACEUTICAL

ENDO GENERICS PAR PHARMACEUTICAL logo

ENDO GENERICS PAR PHARMACEUTICAL

ENDO GENERICS PAR PHARMACEUTICAL logo

ENDO GENERICS PAR PHARMACEUTICAL

ENZYMATIC SUBCISION AND REMODELING (ESR)

ENZYMATIC SUBCISION AND REMODELING (ESR)

E.P.I.C. ELEVATING PRACTICES. INSPIRING CONSUMERS.

E.P.I.C. ELEVATING PRACTICES. INSPIRING CONSUMERS.

E.P.I.C. ELEVATING PRACTICES. INSPIRING CONSUMERS.

E.P.I.C. ELEVATING PRACTICES. INSPIRING CONSUMERS.